SPARK: Supporting Physical Activity Through Reality-Augmented Knowledge in COPD (SPARK)
Acceptability of an Augmented Reality Virtual Coach for Physical Exercise Practice in Patients With Chronic Obstructive Pulmonary Disease: a Multicenter Study
Chronic obstructive pulmonary disease (COPD) is associated with dyspnea, reduced physical activity, muscle deconditioning, and impaired quality of life. Pulmonary rehabilitation is an effective non-pharmacological intervention, but access remains limited and long-term adherence to physical exercise is often difficult to maintain. Augmented reality may provide an innovative approach to support exercise practice by offering real-time visual and auditory guidance while allowing patients to remain anchored in their real environment.
The SPARK study is a multicenter, interventional, non-randomized, proof-of-concept study designed to assess the acceptability of an augmented reality virtual coach for physical exercise in adults with COPD. Participants will attend a single experimental session including baseline questionnaires, presentation of the augmented reality headset, a short immersive exercise session guided by a virtual coach, and post-immersion assessments. Acceptability will be evaluated using the Technology Acceptance Model 3 questionnaire before and after immersion. User experience will also be explored through focus group discussions analyzed according to UXive dimensions.
The study aims to determine whether this technology is acceptable to patients with COPD and to identify factors that may facilitate or limit its future integration into pulmonary rehabilitation pathways.
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Angélique Picard
- Correo electrónico: Angelique.picard@ch-havre.fr
Copia de seguridad de contactos de estudio
- Nombre: Clement Medrinal, PhD
- Número de teléfono: +33664615110
- Correo electrónico: clement.medrinal@ch-havre.fr
Ubicaciones de estudio
-
-
-
Montivilliers, Francia, 76290
- Reclutamiento
- Groupe Hospitalier du Havre
-
Contacto:
- Clément Medrinal
- Número de teléfono: 0664615110
- Correo electrónico: clement.medrinal@ch-havre.fr
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age ≥ 18 years Diagnosis of chronic obstructive pulmonary disease (COPD) confirmed according to GOLD recommendations, defined by a post-bronchodilator FEV1/FVC ratio < 0.70 No exacerbation during the previous month, defined as hospitalization or major therapeutic modification related to worsening respiratory symptoms Written informed consent obtained before any study-related procedure Affiliation to a social security system
Exclusion Criteria:
- COPD exacerbation during the previous month Major motor disorders, disabling osteoarticular conditions, or significant functional dependence preventing safe participation in physical exercises Insufficient cognitive or language abilities to understand instructions, complete questionnaires, or participate in the semi-structured interview Photosensitive epilepsy Uncorrected or atypical visual and/or hearing impairment Patient under legal guardianship, curatorship, or incarcerated Pregnant or breastfeeding woman
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Augmented Reality Virtual Coach Session
Participants with chronic obstructive pulmonary disease will attend a single experimental session using an augmented reality headset with a virtual coach. After baseline questionnaires and headset presentation, participants will complete an approximately 20-minute guided exercise session including calf raises, sit-to-stand exercises, and stretching. The virtual coach provides standardized instructions and corrective feedback during strengthening exercises. Acceptability will be assessed before and after immersion using the TAM3 questionnaire, followed by a focus group exploring user experience. |
Participants will use an augmented reality headset delivering a virtual coach-guided exercise session. The intervention consists of a single approximately 20-minute immersive session performed in a secured environment. The virtual coach provides standardized instructions and corrective feedback during strengthening exercises. The session includes calf raises, sit-to-stand exercises, and stretching. The intervention is designed to assess the acceptability and user experience of an augmented reality-based exercise support tool in adults with chronic obstructive pulmonary disease.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Global Acceptability Score of the Augmented Reality Virtual Coach
Periodo de tiempo: Immediately after the augmented reality immersion session, during the single study visit
|
Acceptability will be assessed using the global score of the adapted Technology Acceptance Model 3 questionnaire completed immediately after the augmented reality immersion session. Items are rated on a 7-point Likert scale, with higher scores indicating greater acceptability. The mean global score will be compared with the theoretical neutral value of 4. |
Immediately after the augmented reality immersion session, during the single study visit
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Anaick Perrochon, PhD, Université Limoges
- Director de estudio: Bonnevie Tristan, PhD, ADIR Association
- Director de estudio: Benoit Borel, PhD, Université Limoges
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2026-A00566-45
- 2026-A00566-45 (Identificador de registro: ANSM)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .